These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26254977)

  • 21. Maternal and neonatal data collection systems in low- and middle-income countries for maternal vaccines active safety surveillance systems: A scoping review.
    Berrueta M; Ciapponi A; Bardach A; Cairoli FR; Castellano FJ; Xiong X; Stergachis A; Zaraa S; Meulen AS; Buekens P;
    BMC Pregnancy Childbirth; 2021 Mar; 21(1):217. PubMed ID: 33731029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the safety of influenza immunization during pregnancy: the Vaccine Safety Datalink.
    Kharbanda EO; Vazquez-Benitez G; Shi WX; Lipkind H; Naleway A; Molitor B; Kuckler L; Olsen A; Nordin JD
    Am J Obstet Gynecol; 2012 Sep; 207(3 Suppl):S47-51. PubMed ID: 22920059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Burden of severe maternal morbidity and association with adverse birth outcomes in sub-Saharan Africa and south Asia: protocol for a prospective cohort study.
    AMANHI Maternal Morbidity study group
    J Glob Health; 2016 Dec; 6(2):020601. PubMed ID: 27648256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Death audits and reviews for reducing maternal, perinatal and child mortality.
    Willcox ML; Price J; Scott S; Nicholson BD; Stuart B; Roberts NW; Allott H; Mubangizi V; Dumont A; Harnden A
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012982. PubMed ID: 32212268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surveillance of adverse events following vaccination in the French armed forces, 2011-2012.
    Mayet A; Duron S; Meynard JB; Koeck JL; Deparis X; Migliani R
    Public Health; 2015 Jun; 129(6):763-8. PubMed ID: 25890634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.
    Ropero-Álvarez AM; Whittembury A; Bravo-Alcántara P; Kurtis HJ; Danovaro-Holliday MC; Velandia-González M
    Vaccine; 2015 Jan; 33(1):187-92. PubMed ID: 25444798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protocol of a prospective and multicentre China Teratology Birth Cohort (CTBC): association of maternal drug exposure during pregnancy with adverse pregnancy outcomes.
    Zhou Y; Tao J; Wang K; Deng K; Wang Y; Zhao J; Chen C; Wu T; Zhou J; Zhu J; Li X
    BMC Pregnancy Childbirth; 2021 Sep; 21(1):593. PubMed ID: 34470618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suggestions for improving the monitoring of adverse events following immunization in New Zealand.
    Miller M; Turner N
    N Z Med J; 2002 Sep; 115(1162):U186. PubMed ID: 12386665
    [No Abstract]   [Full Text] [Related]  

  • 29. The Safety of PsA-TT in Pregnancy: An Assessment Performed Within the Navrongo Health and Demographic Surveillance Site in Ghana.
    Wak G; Williams J; Oduro A; Maure C; Zuber PL; Black S
    Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S489-92. PubMed ID: 26553679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older.
    Pillsbury AJ; Fathima P; Quinn HE; Cashman P; Blyth CC; Leeb A; Macartney KK
    JAMA Netw Open; 2020 May; 3(5):e204079. PubMed ID: 32369177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The monitoring of adverse events following immunization.
    Tatley M
    N Z Med J; 2002 Nov; 115(1165):U247; author reply U247. PubMed ID: 12552289
    [No Abstract]   [Full Text] [Related]  

  • 32. Prenatal Tdap immunization and risk of maternal and newborn adverse events.
    Layton JB; Butler AM; Li D; Boggess KA; Weber DJ; McGrath LJ; Becker-Dreps S
    Vaccine; 2017 Jul; 35(33):4072-4078. PubMed ID: 28669620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duloxetine and pregnancy outcomes: safety surveillance findings.
    Hoog SL; Cheng Y; Elpers J; Dowsett SA
    Int J Med Sci; 2013; 10(4):413-9. PubMed ID: 23471302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SAEFVIC: Surveillance of adverse events following immunisation (AEFI) in Victoria, Australia, 2018.
    Clothier HJ; Lawrie J; Lewis G; Russell M; Crawford NW; Buttery JP
    Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32536336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Postmarketing surveillance of secondary effects of vaccines].
    Duclos P
    Rev Epidemiol Sante Publique; 1994; 42(5):425-33. PubMed ID: 7973002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strengthening of causality assessment of adverse events following immunization in the WHO South East Asia and Western Pacific regions: Lessons from the 2014 SEAR inter-country workshop.
    MacDonald NE; Guichard S; Amarasinghe A; Balakrishnan MR;
    Vaccine; 2015 Nov; 33(48):6902-7. PubMed ID: 25617790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lessons learned from COVID-19 vaccine acceptance among pregnant and lactating women from two districts in Kenya to inform demand generation efforts for future maternal RSV vaccines.
    Limaye RJ; Singh P; Fesshaye B; Karron RA
    BMC Pregnancy Childbirth; 2024 Mar; 24(1):221. PubMed ID: 38539077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obstetric and neonatal outcomes in South Africa.
    Cutland CL; Sawry S; Fairlie L; Barnabas S; Frajzyngier V; Roux JL; Izu A; Kekane-Mochwari KE; Vika C; De Jager J; Munson S; Jongihlati B; Stark JH; Absalon J
    Vaccine; 2024 Feb; 42(6):1352-1362. PubMed ID: 38310014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Pathirana J; Muñoz FM; Abbing-Karahagopian V; Bhat N; Harris T; Kapoor A; Keene DL; Mangili A; Padula MA; Pande SL; Pool V; Pourmalek F; Varricchio F; Kochhar S; Cutland CL;
    Vaccine; 2016 Dec; 34(49):6027-6037. PubMed ID: 27449077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-marketing surveillance study of the safety of the HPV-16/18 vaccine in Korea (2017-2021).
    Eun BW; Bahar E; Xavier S; Kim H; Borys D
    Hum Vaccin Immunother; 2023 Dec; 19(1):2184756. PubMed ID: 36896702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.